Home   >  
Cell Cycle/DNA Damage
  >  
CDK

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

CDK

Chemical Structure Cat. No. Product Name CAS No.
LY3405105 Chemical Structure
BCP42676 LY3405105 2326428-25-3
LY3405105 is an orally active CDK7 inhibitor with an IC50 of 92.8 nM. LY3405105 shows potential antineoplastic activity.
MS140 Chemical Structure
BCP42677 MS140 2229974-83-6
MS140 is a specific and highly potent CDK4/6 kinase inhibitor and also a CDK4/6 degrader (PROTAC).
SB1317 Chemical Structure
BCP42651 SB1317 1204918-72-8
SB1317 is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. Zotiraciclib may be useful for the treatment of cancer that crosses the blood brain barrier and acts by depleting Myc through the inhibition of cyclin-dependent kinase 9 (CDK9). It is one of a number of CDK inhibitors under investigation; others targeting CDK9 for the treatment of acute myeloid leukemia include alvocidib and atuveciclib. Myc overexpression is a known factor in many cancers, with 80 percent of glioblastomas characterized by this property.
CDK4 inhibitor compound 12 Chemical Structure
BCP41586 CDK4 inhibitor compound 12 2105956-77-0
CDK4 inhibitor compound 12 is a novel inhibitor of CDK4 with the activity 97 μM.
KB-0742 Chemical Structure
BCP41310 KB-0742 2416873-83-9
KB-0742 is an orally bioavailable, selective CDK9 inhibitor with potent anti-tumor activity in CRPC models.
BSJ-4-116 Chemical Structure
BCP40986 BSJ-4-116 2519823-34-6
BSJ-4-116 selectively degraded CDK12 as assessed through quantitative proteomics.
YKL-5-124 Chemical Structure
BCP40930 YKL-5-124 1957203-01-8
YKL-5-124 is a potent and highly selective covalent CDK7 inhibitor which causes arrest at the G1/S transition and inhibition of E2F-driven gene expression.
GW805758X Chemical Structure
BCP38035 GW805758X GW805758X
GW805758X is a potent inhibitor of CDK-4 which demonstrates enzyme selectivity against VEGFR-2 and GSK3β.
FIT-039 Chemical Structure
BCP37988 FIT-039 1113044-49-7
FIT-039 is a potent, selective CDK9 inhibitor with IC50 of 5.8 uM for CKD9/cyclin T1, suppresses the replication of HSV-1 (IC50=0.69 uM).
CDKI-73 Chemical Structure
BCP37660 CDKI-73 1421693-22-2
CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM. It shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM). The inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin.
123下一页末页共 125 条记录 1 / 13 页 
0086-15971444841